Navigation Links
INCOM Inc. Marks 40th Anniversary as Market Leader in Fused Fiber Optics
Date:9/28/2011

CHARLTON, Mass., Sept. 28, 2011 /PRNewswire/ -- INCOM Inc., the leading commercial manufacturer of fused fiber optic components, marks its 40th anniversary on October 1, 2011. Since its humble beginnings in 1971, INCOM has grown into a worldwide market leader recognized for forging new paths and manufacturing state-of-the-art fiber optic products for scientific, medical, dental and life science applications.

"While our business is highly technical, our products impact ordinary people in extraordinary ways," comments Anthony M. Detarando, President of INCOM.  For example:  

  • INCOM's fiber optic faceplates enhance image quality and significantly improve sensor protection in medical and dental radiography.

  • INCOM's fiber optic tapers and faceplates are used in X-ray crystallography, electron microscopy and high-speed DNA sequencing cameras used in the discovery of new drugs and medications. This results in more usable data, more reliable results and greatly-enhanced speed of processing. Instead of taking many years to map the human genome, INCOM's fiber optic microwell arrays have helped shorten the time to weeks.

  • Proprietary processes from INCOM, including the company's patented MEGAdraw, process have led to the production of fiber optic components that are used in the world's best night vision systems. These include goggles and helmet-mounted displays and cameras as well as heads-up and cockpit displays.

  • INCOM's microcapillary plates also play a vital role in bioterrorism weapons systems detection. This product is also being used in such applications as TOF, PET Scan, Micro-CHP, neutron detection, MCPs and many other novel products.

INCOM has been awarded several federal Small Business Innovation Research (SBIR) grants, including one from the National Science Foundation in 2006 that helped facilitate the manufacturing of microcapillary faceplates. In 2010, the Department of Energy awarded INCOM an SBIR to work in conjunction with their SLAC National Accelerator Laboratory - operated by Stanford University. The objective is to replace a two-mile long particle accelerator with a desktop unit.  That work continues today and is considered to be a key technology in a wide variety of scientific advancements.

INCOM is currently involved in a myriad of new projects including enhanced digital imaging, ultrasonic fingerprinting, digital dental X-raying and the production and marketing of fiber optic faceplates that enable keyboards and displays to be dynamically programmable.

For any comments or more information about INCOM, please refer to http://www.incomusa.com.


'/>"/>
SOURCE INCOM Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Pfizer supports open access publishing for researchers in low-income countries
2. Race/ethnicity, family income and education associated with sugar consumption
3. Solar-powered irrigation significantly improves diet and income in rural sub-Saharan Africa
4. Lower income women report more insurance-based discrimination during pregnancy, delivery
5. Study finds that low-income women living in small cities have higher chance of obesity
6. Greater food insecurity from recession poses increased risk to low income individuals with diabetes
7. Overweight primarily a problem among wealthier women in low- to middle-income countries
8. Pollution tax rebates little help for low-income workers
9. Californias draft Bay Delta conservation plan incomplete; needs better integration to be more scientifically credible
10. NYC science symposium marks Gruber Prize program 10th anniversary
11. Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Fla. , Feb. 16, 2017  MDNA ... revolutionizing the development of liquid biopsy tests based ... entered into an exclusive license agreement with its ... MDNA,s proprietary liquid biopsy test for prostate cancer, ... South Korea . This is the first ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... Feb. 16, 2017  Champions Oncology, Inc. (NASDAQ: ... and sale of advanced technology solutions and products to ... announced the addition of new cohorts of PDX models ... models will expand Champions, product line in hepatocellular cancer, ... cancer, AML, and non-small cell lung cancer (including EGFR ...
(Date:2/16/2017)... and NEW YORK , Feb. ... near completion of their $7M Series B financing, adding ... of the $3.5M led by Mesa Verde Venture Partners ... These resources will be directed towards further accelerating commercial ... a comprehensive genomic profiling test and expanding the Paradigm ...
Breaking Biology Technology: